MedWatch Technologies Inc.

Our mission is to empower people with diabetes and pre-diabetes to better manage their health, with a CGM system that is easier, lower-cost, and less painful.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location San Diego, CA, USA
  • Currency USD
  • Founded January 2022
  • Employees 12
  • Incorporation Type C-corp
  • Website medwatchtech.com

Company Summary

MedWatch Technologies is developing a fully non-invasive glucose monitoring device and accompanying health management platform. We expect to obtain FDA Clearance by EOY 2024. This represents a unique and exciting new solution for managing blood glucose levels.

We have a clear operational model with conservative projected milestones, targeting a generous return to angel/seed investors.

Team

  • CEO/Co-Founder

    CEO, President & successful founder of Tech ventures.
    30+Years Navy Reserve. Worked on NASA Projects.
    MedWatch Patents. Industries: Wireless, Publishing, Manufacturing, Semiconductors, Medical Devices,
    Genetics, Microbes

  • COO, Sam Zaidspiner, launched and grew a Class 2 medical device company, a surgical irrigation device to reduce surgical infections. Sold into 3,000 hospitals, 3 million units, at $70/unit. Nearing M&A transaction to deliver generous return to investors. WEBSITE: www.irrisept.com Sam Zaidspiner is an operational leader and has launched multiple products.

Advisors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free